J Chest Surg.
2025 Nov;58(6):237-238. 10.5090/jcs.25.139.
Commentary: Prognostic Implications of EGFR Exon 20 Insertions in Resected Non–Small Cell Lung Cancer
- Affiliations
-
- 1Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- KMID: 2575985
- DOI: http://doi.org/10.5090/jcs.25.139
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Epidermal Growth Factor Receptor Exon 20 Insertion in Early Resected Non-Small Cell Lung Cancer: A Retrospective, SingleCenter Study in Taiwan
- Prognostic Value of EGFR Mutation Subtypes After Linac-Based Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastasis From EGFR-Mutated Non-Small Cell Lung Cancer
- Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
- Expression of EGFR in Non-small Cell Lung Cancer and its Effects on Survival
- Chronicles of EGFR Tyrosine Kinase Inhibitors: Targeting EGFR C797S Containing Triple Mutations
